Article Details
Retrieved on: 2018-03-07 20:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>In February, Roche bought <b>Flatiron Health</b>, a New York life sciences/tech hybrid company that amasses data on cancer patients, for $1.9 billion. Since then, two other New York-born startups, Kallyope and Quentis Therapeutics, each raised large funding rounds: $66 million and $48 million, respectively.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here